Annual Accounts Payable
$4.28 M
+$2.08 M+94.35%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual accounts payable is $4.28 million, with the most recent change of +$2.08 million (+94.35%) on December 31, 2023.
- During the last 3 years, CRMD annual accounts payable has risen by +$3.15 million (+279.37%).
- CRMD annual accounts payable is now at all-time high.
Performance
CRMD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.34 M
-$2.00 M-59.82%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly accounts payable is $1.34 million, with the most recent change of -$2.00 million (-59.82%) on September 30, 2024.
- Over the past year, CRMD quarterly accounts payable has dropped by -$2.94 million (-68.60%).
- CRMD quarterly accounts payable is now -82.95% below its all-time high of $7.88 million, reached on September 30, 2018.
Performance
CRMD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CRMD Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.3% | -68.6% |
| 3 y3 years | +279.4% | -39.0% |
| 5 y5 years | +65.3% | +42.5% |
CRMD Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.3% | -68.6% | at low |
| 5 y | 5-year | at high | +317.8% | -68.6% | +42.5% |
| alltime | all time | at high | +678.7% | -83.0% | +159.9% |
CorMedix Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.34 M(-59.8%) |
| Jun 2024 | - | $3.34 M(+18.3%) |
| Mar 2024 | - | $2.83 M(-34.0%) |
| Dec 2023 | $4.28 M(+94.3%) | $4.28 M(+79.4%) |
| Sep 2023 | - | $2.39 M(-17.7%) |
| Jun 2023 | - | $2.90 M(+100.5%) |
| Mar 2023 | - | $1.45 M(-34.3%) |
| Dec 2022 | $2.20 M(-0.3%) | $2.20 M(+24.6%) |
| Sep 2022 | - | $1.77 M(-29.2%) |
| Jun 2022 | - | $2.50 M(+43.5%) |
| Mar 2022 | - | $1.74 M(-21.3%) |
| Dec 2021 | $2.21 M(+95.9%) | $2.21 M(+99.6%) |
| Sep 2021 | - | $1.11 M(+17.3%) |
| Jun 2021 | - | $943.30 K(-37.1%) |
| Mar 2021 | - | $1.50 M(+33.0%) |
| Dec 2020 | $1.13 M(+10.1%) | $1.13 M(-43.2%) |
| Sep 2020 | - | $1.99 M(+43.3%) |
| Jun 2020 | - | $1.39 M(+4.0%) |
| Mar 2020 | - | $1.33 M(+30.1%) |
| Dec 2019 | $1.02 M(-60.4%) | $1.02 M(-2.9%) |
| Sep 2019 | - | $1.05 M(+16.4%) |
| Jun 2019 | - | $906.10 K(-38.0%) |
| Mar 2019 | - | $1.46 M(-43.5%) |
| Dec 2018 | $2.59 M(+43.2%) | $2.59 M(-67.2%) |
| Sep 2018 | - | $7.88 M(+7.8%) |
| Jun 2018 | - | $7.31 M(+99.7%) |
| Mar 2018 | - | $3.66 M(+102.4%) |
| Dec 2017 | $1.81 M | $1.81 M(+28.4%) |
| Sep 2017 | - | $1.41 M(-20.3%) |
| Jun 2017 | - | $1.77 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $1.73 M(+4.9%) |
| Dec 2016 | $1.65 M(-3.7%) | $1.65 M(-6.4%) |
| Sep 2016 | - | $1.76 M(+58.6%) |
| Jun 2016 | - | $1.11 M(-29.9%) |
| Mar 2016 | - | $1.58 M(-7.5%) |
| Dec 2015 | $1.71 M(+91.3%) | $1.71 M(+20.0%) |
| Sep 2015 | - | $1.42 M(+24.8%) |
| Jun 2015 | - | $1.14 M(-20.1%) |
| Mar 2015 | - | $1.43 M(+59.9%) |
| Dec 2014 | $893.40 K(-4.9%) | $893.40 K(+20.7%) |
| Sep 2014 | - | $740.30 K(-12.8%) |
| Jun 2014 | - | $848.60 K(-17.4%) |
| Mar 2014 | - | $1.03 M(+9.3%) |
| Dec 2013 | $939.80 K(+1.2%) | $939.80 K(-3.1%) |
| Sep 2013 | - | $969.80 K(-34.9%) |
| Jun 2013 | - | $1.49 M(+13.5%) |
| Mar 2013 | - | $1.31 M(+41.3%) |
| Dec 2012 | $928.60 K(+1.7%) | $928.60 K(+1.2%) |
| Sep 2012 | - | $917.60 K(-7.7%) |
| Jun 2012 | - | $993.80 K(-30.2%) |
| Mar 2012 | - | $1.42 M(+55.9%) |
| Dec 2011 | $913.50 K(-19.8%) | $913.50 K(-7.7%) |
| Sep 2011 | - | $990.10 K(-31.1%) |
| Jun 2011 | - | $1.44 M(+11.1%) |
| Mar 2011 | - | $1.29 M(+13.5%) |
| Dec 2010 | $1.14 M(+107.3%) | $1.14 M(+120.3%) |
| Sep 2010 | - | $517.10 K(-35.7%) |
| Jun 2010 | - | $803.60 K(-23.2%) |
| Mar 2010 | - | $1.05 M(+90.3%) |
| Dec 2009 | $549.60 K | $549.60 K |
FAQ
- What is CorMedix annual accounts payable?
- What is the all time high annual accounts payable for CorMedix?
- What is CorMedix annual accounts payable year-on-year change?
- What is CorMedix quarterly accounts payable?
- What is the all time high quarterly accounts payable for CorMedix?
- What is CorMedix quarterly accounts payable year-on-year change?
What is CorMedix annual accounts payable?
The current annual accounts payable of CRMD is $4.28 M
What is the all time high annual accounts payable for CorMedix?
CorMedix all-time high annual accounts payable is $4.28 M
What is CorMedix annual accounts payable year-on-year change?
Over the past year, CRMD annual accounts payable has changed by +$2.08 M (+94.35%)
What is CorMedix quarterly accounts payable?
The current quarterly accounts payable of CRMD is $1.34 M
What is the all time high quarterly accounts payable for CorMedix?
CorMedix all-time high quarterly accounts payable is $7.88 M
What is CorMedix quarterly accounts payable year-on-year change?
Over the past year, CRMD quarterly accounts payable has changed by -$2.94 M (-68.60%)